Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Ablynx strengthens cash position

Country: Belgium

Ablynx NV improved its revenue and cash position in the first half of 2014 largely due to upfront payments from research partners Merck & Co Inc, AbbVie Inc and Merck Serono. The Merck programme is investigating immune checkpoint inhibitors for cancer.

Read more

ArGEN-X gives clinical update

Country: Belgium

Fresh from a successful European initial public share offering, the Belgian antibody developer ArGEN-X NV has given an update on the progress of its two lead products directed at potential cancer indications.

Read more

Medtronic purchases Dutch brain-stimulation company

Country: United States

Read more

J&J affiliate unit buys Swiss antibody firm

Country: United Kingdom

Read more

Japanese stem cell scientist dies

Country: Japan

Read more

FDA comments on mesenchymal stem cells

Country: United States

Read more

Gene therapy acquisition

Country: Netherlands

Read more

Malaria protein described

Country: Denmark

Read more

MorphoSys in prostate cancer deal

Country: Germany

Read more

Basilea reports loss, files NDA for anti-infective

Country: Switzerland

Read more

4SC directors resign

Country: Germany

Read more

Skyepharma in deal with Pulmagen for COPD therapy

Country: United Kingdom

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

How Britain champions medical innovation

UKasBiocentreSept2014.pdf

Highlights of the July-Aug 2014 MedNous issue

The July-Aug 2014 MedNous features:

Latest Mednous cover
  • Business Strategy
    Why Big Pharma is
    seizing the orphan drug
    opportunity
  • Oncology
    Hitting the accelerator
    in immunotherapy
    By Frederic Triebel
  • Regulatory
    Next step for clinical trial
    transparency
  • Commentary
    Who has the lead in
    genomic research?
    By Florian Bazant-Hegemark
    and Gareth Williams
  • Markets
    Quarterly stock market review
    AbbVie wins Shire

The latest MedNous journal. Subscribe to download.

Recent Appointments